Resmed IncChange company Symbol lookupSelect an option...RMD Resmed IncNEOV NeoVolta IncSYBX Synlogic IncFIISO Financial Institutions IncKA Kineta IncTCS Container Store Group IncMLGO MicroAlgo IncINDI indie Semiconductor IncJCI Johnson Controls International PLCFPAY FlexShopper IncGo
Change company Symbol lookup
Select an option...
RMD Resmed Inc
NEOV NeoVolta Inc
SYBX Synlogic Inc
FIISO Financial Institutions Inc
KA Kineta Inc
TCS Container Store Group Inc
MLGO MicroAlgo Inc
INDI indie Semiconductor Inc
JCI Johnson Controls International PLC
FPAY FlexShopper Inc
Health Care : Health Care Equipment & Supplies | Mid Cap Growth
Company profileResMed Inc. is a holding company. The Company, through its subsidiaries, is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease, neuromuscular disease and other chronic diseases. The Company’s segments include Sleep and Respiratory Care and Software as a Service. SDB includes obstructive sleep apnea and other respiratory disorders that occur during sleep. Its cloud-based digital software health applications, along with its devices, are designed to provide connected care to improve patient outcomes. Its portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, and cloud-based software and informatics solutions. Its comprehensive out-of-hospital software platforms support the professionals and caregivers.
|
|
|
|
| |
| Latest Earnings (Q4 ending 06/2023) | Upcoming Announcement (Q1 ending 09/2023) | ||||||
|---|---|---|---|---|---|---|---|
| Q4 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. | $1.60 | Estimate increased in year leading up to announcement | 1.01% | Q1 consensus estimate | $1.66 | Q1 consensus estimate is higher than previous yr's Q1 actual | 9.93% |
| Q4 Consensus estimate | $1.69 | Previous year's Q1 actual | $1.51 | ||||
Quarterly Consensus Estimate Trends over Time
RMD's fiscal year ends in June
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2023. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.